Robert T. Foster

2.3k total citations
83 papers, 1.9k citations indexed

About

Robert T. Foster is a scholar working on Pharmacology, Oncology and Pharmacology. According to data from OpenAlex, Robert T. Foster has authored 83 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmacology, 23 papers in Oncology and 18 papers in Pharmacology. Recurrent topics in Robert T. Foster's work include Drug Transport and Resistance Mechanisms (20 papers), Analytical Methods in Pharmaceuticals (16 papers) and Analytical Chemistry and Chromatography (13 papers). Robert T. Foster is often cited by papers focused on Drug Transport and Resistance Mechanisms (20 papers), Analytical Methods in Pharmaceuticals (16 papers) and Analytical Chemistry and Chromatography (13 papers). Robert T. Foster collaborates with scholars based in Canada, United States and South Korea. Robert T. Foster's co-authors include Fakhreddin Jamali, John S. Grundy, Anthony S. Russell, Daren Ure, Lise Eliot, Daniel J. Trepanier, F. Jamali, Derrick G. Freitag, F. M. Pasutto and Randall W. Yatscoff and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Journal of Controlled Release.

In The Last Decade

Robert T. Foster

82 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert T. Foster Canada 27 512 483 456 340 339 83 1.9k
Kevin B. Alton United States 26 501 1.0× 272 0.6× 386 0.8× 691 2.0× 545 1.6× 49 2.8k
Francis L. S. Tse Japan 28 265 0.5× 496 1.0× 486 1.1× 721 2.1× 270 0.8× 110 2.7k
Eric Woolf United States 32 353 0.7× 785 1.6× 566 1.2× 572 1.7× 268 0.8× 96 2.7k
H. Thomas Karnes United States 25 256 0.5× 399 0.8× 826 1.8× 763 2.2× 193 0.6× 136 2.7k
B. Oosterhuis Netherlands 25 634 1.2× 333 0.7× 183 0.4× 377 1.1× 426 1.3× 74 2.1k
John Ayrton United Kingdom 23 149 0.3× 340 0.7× 535 1.2× 396 1.2× 235 0.7× 35 1.5k
Shrikant V. Dighe United States 11 194 0.4× 336 0.7× 317 0.7× 402 1.2× 210 0.6× 20 1.7k
Rabindra Patnaik United States 8 215 0.4× 368 0.8× 209 0.5× 397 1.2× 150 0.4× 11 1.8k
Alfred Tonelli United States 12 251 0.5× 434 0.9× 218 0.5× 477 1.4× 155 0.5× 25 2.0k
I.J. McGilveray Canada 21 240 0.5× 381 0.8× 318 0.7× 317 0.9× 123 0.4× 70 1.6k

Countries citing papers authored by Robert T. Foster

Since Specialization
Citations

This map shows the geographic impact of Robert T. Foster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert T. Foster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert T. Foster more than expected).

Fields of papers citing papers by Robert T. Foster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert T. Foster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert T. Foster. The network helps show where Robert T. Foster may publish in the future.

Co-authorship network of co-authors of Robert T. Foster

This figure shows the co-authorship network connecting the top 25 collaborators of Robert T. Foster. A scholar is included among the top collaborators of Robert T. Foster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert T. Foster. Robert T. Foster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harrison, Stephen A., Patrick Mayo, Todd Hobbs, et al.. (2025). Rencofilstat Treatment Improves Liver Function in MASH With Advanced Fibrosis as Quantified by HepQuant DuO. Liver International. 45(3). e70036–e70036. 1 indexed citations
2.
Bobardt, Michael, et al.. (2024). Cyclophilin D knockout significantly prevents HCC development in a streptozotocin-induced mouse model of diabetes-linked NASH. PLoS ONE. 19(4). e0301711–e0301711. 4 indexed citations
3.
Bobardt, Michael, et al.. (2024). Mice lacking cyclophilin B, but not cyclophilin A, are protected from the development of NASH in a diet and chemical-induced model. PLoS ONE. 19(3). e0298211–e0298211. 5 indexed citations
4.
Bobardt, Michael, et al.. (2023). The Cyclophilin Inhibitor Rencofilstat Decreases HCV-Induced Hepatocellular Carcinoma Independently of Its Antiviral Activity. Viruses. 15(10). 2099–2099. 3 indexed citations
5.
Mayo, Patrick, et al.. (2022). Effect of a High‐Fat Meal on Single‐Dose Rencofilstat (CRV431) Oral Bioavailability in Healthy Human Subjects. Clinical Pharmacology in Drug Development. 12(3). 287–293. 2 indexed citations
6.
Bobardt, Michael, Magnus J. Hansson, Patrick Mayo, et al.. (2020). Structurally distinct cyclosporin and sanglifehrin analogs CRV431 and NV556 suppress established HCV infection in humanized-liver mice. PLoS ONE. 15(8). e0237236–e0237236. 11 indexed citations
7.
8.
Eliot, Lise, Robert T. Foster, & Fakhreddin Jamali. (1999). Effects of Hyperlipidemia on the Pharmacokinetics of Nifedipine in the Rat. Pharmaceutical Research. 16(2). 309–313. 33 indexed citations
9.
Grundy, John S., Lise Eliot, Kenneth Kulmatycki, & Robert T. Foster. (1998). Grapefruit juice and orange juice effects on the bioavailability of nifedipine in the rat. Biopharmaceutics & Drug Disposition. 19(3). 175–183. 28 indexed citations
10.
Carr, Robert A., Gilles Caillé, Anh Ho Ngoc, & Robert T. Foster. (1995). Stereospecific high-performance liquid chromatographic assay of ketoprofen in human plasma and urine. Journal of Chromatography B Biomedical Sciences and Applications. 668(1). 175–181. 20 indexed citations
11.
12.
Foster, Robert T., Robert Carr, Franco M. Pasutto, & James Longstreth. (1995). Stereospecific high-performance liquid chromatographic assay of lomefloxacin in human plasma. Journal of Pharmaceutical and Biomedical Analysis. 13(10). 1243–1248. 24 indexed citations
13.
Foster, Robert T., et al.. (1994). Stereospecific high-performance liquid chromatographic assay of zopiclone in human plasma. Journal of Chromatography B Biomedical Sciences and Applications. 658(1). 161–166. 24 indexed citations
14.
Freitag, Derrick G., Robert T. Foster, Ronald T. Coutts, & F. M. Pasutto. (1993). High-performance liquid chromatographic method for resolving the enantiomers of mexiletine and two major metabolites isolated from microbial fermentation media. Journal of Chromatography B Biomedical Sciences and Applications. 616(2). 253–259. 17 indexed citations
15.
Carr, Robert, Robert T. Foster, Richard Lewanczuk, & Peter Hamilton. (1992). Pharmacokinetics of Sotalol Enantiomers in Humans. The Journal of Clinical Pharmacology. 32(12). 1105–1109. 18 indexed citations
16.
Carr, Robert A., et al.. (1991). Stereospeciflc High-Performance Liquid Chromatographic Assay of Sotalol in Plasma. Pharmaceutical Research. 8(9). 1195–1198. 32 indexed citations
17.
Jamali, Fakhreddin, et al.. (1990). Ketoprofen Pharmacokinetics in Humans: Evidence of Enantiomeric Inversion and Lack of Interaction. Journal of Pharmaceutical Sciences. 79(5). 460–461. 48 indexed citations
18.
Piquette‐Miller, Micheline, Robert T. Foster, F. M. Pasutto, & Fakhreddin Jamali. (1990). Stereospecific high-performance liquid chromatographic assay of acebutolol in human plasma and urine. Journal of Chromatography B Biomedical Sciences and Applications. 526(1). 129–137. 33 indexed citations
19.
Foster, Robert T., Fakhreddin Jamali, & Anthony S. Russell. (1989). Pharmacokinetics of ketoprofen enantiomers in cholecystectomy patients: influence of probenecid. European Journal of Clinical Pharmacology. 37(6). 589–594. 17 indexed citations
20.
Foster, Robert T., et al.. (1988). Pharmacokinetics of Ketoprofen Enantiomers in Young and Elderly Arthritic Patients following Single and Multiple Doses. Journal of Pharmaceutical Sciences. 77(3). 191–195. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kevin B. Alton Breakdown of academic impact, for papers by Francis L. S. Tse Breakdown of academic impact, for papers by Eric Woolf Breakdown of academic impact, for papers by H. Thomas Karnes Breakdown of academic impact, for papers by B. Oosterhuis Breakdown of academic impact, for papers by John Ayrton Breakdown of academic impact, for papers by Shrikant V. Dighe Breakdown of academic impact, for papers by Rabindra Patnaik Breakdown of academic impact, for papers by Alfred Tonelli Breakdown of academic impact, for papers by I.J. McGilveray
Rankless by CCL
2026